AXL

There are 25 papers on AXL in aging research: 1 trial and 6 observational studies in people, 14 in animals, 1 in cells. The newest story, Oct 7, 2026: “Blood proteins linked aging measures to fatty liver disease risk”.

Gene

25 papers study it5 findings

HGNCNCBI GeneTaxon

1 new paper in 30 daysSee all 25 papers on AXL

At a glance

The findings reach mice, none yet in people. 4 independent labs in 4 countries; 8 trials.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 4 independent labs in 4 countries
  • 8 trials
  • Funders: National Natural Science Foundation of China and others
  • 8 of 8 trials sponsored by developers of drugs aimed at it
  • Human trial1
  • Humans6
  • Animals14
  • Cells1
  • In silico3

Effects

4

Osteogenic differentiation marker expression

is required forin mouse cells1

1 study
  1. AXL is required for osteogenic differentiation marker expression in mouse cells (Required for the response to mangiferin, shown by AXL knockdown).

    CellsRequired for the response to mangiferin, shown by AXL knockdownMC3T3-E1

More on Osteogenic differentiation marker expression

Cellular senescence

is required forin mice1

1 study
  1. AXL is required for cellular senescence in mice (anti-senescence effect of testosterone, shown by knockout).

    Animalsanti-senescence effect of testosterone, shown by knockoutblood vessel

More on Cellular senescence

Platelet-biased hematopoietic stem cells

downin mice1

1 study
  1. AXL decreases platelet-biased hematopoietic stem cells in mice (shown by Axl loss in young mice).

    Animalsshown by Axl loss in young mice

Cardiac remodeling improvement

is required forin mice1

1 study
  1. AXL is required for cardiac remodeling improvement in mice (shown by Axl knockout; Axl-/- mice receiving testosterone showed no obvious improvement).

    Animalsshown by Axl knockout; Axl-/- mice receiving testosterone showed no obvious improvementheart

Upstream

1

MIR34A

downin human cells1

1 study
  1. MIR34A decreases AXL in human cells.

    Cells

More on MIR34A

Funding

2 grants since 2023

National Institute on Aging$3.1M

Latest

Dec 2025: 1Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 1Sep 2026: 1Oct 2026: 1Nov 2026: 07 papers in 12 months

See all 25 papers on AXL